FDA Approves Eli Lilly's GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
schedule
18:56
visibility
45 görüntüleme
Kaynak: Wired
Orijinal makaleyi oku →
auto_awesome Bu makale otomatik olarak çevrilmiştir ve yanlışlıklar içerebilir.
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.